Continuous Positive Airway Pressure for the Treatment of Sleep Apnea

Otolaryngologic Clinics of North America

Volumn 40, Issue 4, 2007, Pages 807-827

  Chowdhuri, Susmita ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR EFFECT; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEVICE; FACE MASK; HUMAN; NEUROPSYCHOLOGY; PATIENT EDUCATION; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SLEEP APNEA SYNDROME; TREATMENT OUTCOME;

ALGORITHMS; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; EQUIPMENT DESIGN; HUMANS; NEUROPSYCHOLOGICAL TESTS; PATIENT COMPLIANCE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 34250803211     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2007.04.011     Document Type: Review

References (108)

1. Phillipson E.A. Sleep apnea: a major public health problem. N Engl J Med 328 17 (1993) 1271-1273
2. Young T., Palta M., Dempsey J., et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 17 (1993) 1230-1235
3. Durmer J.S., and Dinges D.F. Neurocognitive consequences of sleep deprivation. Semin Neurol 25 1 (2005) 117-129
4. Shahar E., Whitney C.W., Redline S., et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163 1 (2001) 19-25
5. Sullivan C.E., Issa F.G., Berthon-Jones M., et al. Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1 8225 (1981) 862-865
6. Abbey N.C., Cooper K.R., and Kwentus J.A. Benefit of nasal CPAP in obstructive sleep apnea is due to positive pharyngeal pressure. Sleep 12 5 (1989) 420-422
7. ATS Statement. Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. Am J Respir Crit Care Med 150 6 Pt 1 (1994) 1738-1745
8. Gay P., Weaver T., Loube D., et al., Positive Airway Pressure Task Force, Standards of Practice Committee, American Academy of Sleep Medicine. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 29 3 (2006) 381-401
9. American Academy of Sleep Medicine. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 22 5 (1999) 667-689
10. Smith P.L., Wise R.A., Gold A.R., et al. Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol 64 2 (1988) 789-795
11. Heinzer R.C., Stanchina M.L., Malhotra A., et al. Lung volume and continuous positive airway pressure requirements in obstructive sleep apnea. Am J Respir Crit Care Med 172 1 (2005) 114-117
12. Series F., Cormier Y., Couture J., et al. Changes in upper airway resistance with lung inflation and positive airway pressure. J Appl Physiol 68 3 (1990) 1075-1079
13. Moura S.M.T., Bittencourt L.R., and Bagnato M.C. Acute effect of nasal continuous positive air pressure on the ventilator control of patients with obstructive sleep apnea. Respiration 68 3 (2001) 243-249
14. Rapoport D.M., Garay S.M., and Goldring R.M. Nasal CPAP in obstructive sleep apnea: mechanisms of action. Bull Eur Physiopathol Respir 19 6 (1983) 616-620
15. Sanders M.H. Nasal CPAP effect on patterns of sleep apnea. Chest 86 6 (1984) 839-844
16. Loube D.I., Gay P.C., Strohl K.P., et al. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest 15 3 (1999) 863-866
17. Young T., Peppard P., Palta M., et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157 15 (1997) 1746-1752
18. Nieto F.J., Young T.B., Lind B.K., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. J Am Med Assoc 283 14 (2000) 1829-1836
19. Guilleminault C., Partinen M., Quera-Salva M.A., et al. Determinants of daytime sleepiness in obstructive sleep apnea. Chest 94 1 (1988) 32-37
20. Bearpark H., Grunstein R., Touyz S., et al. Cognitive and psychological dysfunction in sleep apnea before and after treatment with CPAP. Sleep Res 16 (1987) 303
21. Young T., Blustein J., Finn L., et al. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 20 8 (1997) 608-613
22. Engleman H.E., Kingshott R.N., Wraith P.K., et al. Randomized placebo-controlled crossover trial of continuous positive airways pressure for mild obstructive apnea/hypopnea syndrome. Am J Respir Crit Care Med 159 2 (1999) 461-467
23. Redline S., Adams N., Strauss M.E., et al. Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 157 3 Pt 1 (1998) 858-865
24. Boland L.L., Shahar E., Iber C., et al., Sleep Heart Health Study (SHHS) Investigators. Measures of cognitive function in persons with varying degrees of sleep-disordered breathing: the Sleep Heart Health Study. J Sleep Res 11 3 (2002) 265-272
25. Standards of Practice Committee of the ASDA. Practice parameters for the indication for polysomnography and related procedures. Sleep 20 6 (1997) 406-422
26. Oksenberg A., Silverberg D.S., Arons E., et al. The Sleep supine position has a major effect on optimal nasal continuous positive airway pressure: relationship with rapid eye movements and non-rapid eye movements sleep, body mass index, respiratory disturbance index, and age. Chest 116 4 (1999) 1000-1006
27. Oliver Z., and Victor Hoffstein V. Predicting effective continuous positive airway pressure. Chest 117 4 (2000) 1061-1064
28. Hoffstein V., and Mateika S. Predicting nasal continuous positive airway pressure. Am J Respir Crit Care Med 150 2 (1994) 486-488
29. Rowley J.A., Aboussouan L.S., and Badr M.S. The use of clinical prediction formulas in the evaluation of obstructive sleep apnea. Sleep 23 7 (2000) 929-938
30. Sanders M.H., Costantion J.P., Strollo Jr. P.J., et al. The impact of split-night polysomnography for diagnosis and positive pressure therapy titration on treatment acceptance and adherence in sleep apnea/hypopnea. Sleep 23 1 (2000) 17-24
31. Yamashiro Y., and Kryger M.H. CPAP titration for sleep apnea using a split-night protocol. Chest 107 1 (1995) 62-66
32. McArdle N., Grove A., Devereux G., et al. Splitnight versus full-night studies for sleep apnoea/hypopnoea syndrome. Eur Respir J 15 4 (2000) 670-675
33. Criner G.J., Brennan K., Travaline J.M., et al. Efficacy and compliance with noninvasive positive pressure ventilation in patients with chronic respiratory failure. Chest 116 3 (1994) 667-675
34. Reeves-Hoche M.K., Meck R., Zwillich C.W., et al. An objective evaluation of patient compliance. Am J Respir Crit Care Med 149 1 (1994) 149-154
35. Berry R.B., Parish J.M., and Hartse K.M. The use of auto-titrating continuous positive airway pressure for treatment of adult obstructive sleep apnea. An American Academy of Sleep Medicine review. Sleep 25 2 (2002) 148-173
36. Krieger J. Therapeutic use of auto-CPAP. Sleep Med Rev 3 2 (1999) 159-174
37. AASM Standards of Practice Committee. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine report. Sleep 25 2 (2002) 143-147
38. West S.D., Jones D.R., and Stradling J.R. Comparison of three ways to determine and deliver pressure during nasal CPAP therapy for obstructive sleep apnoea. Thorax 61 3 (2006) 226-231
39. Ayas N.T., Patel S.R., Malhotra A., et al. Auto-titrating versus standard continuous positive airway pressure for the treatment of obstructive sleep apnea: results of a meta-analysis. Sleep 27 2 (2004) 249-253
40. Haniffa M, Lasserson TJ, Smith I. Interventions to improve compliance with continuous positive airway pressure for obstructive sleep apnoea. Cochrane Database Syst Rev Oct 18, 2004;(4).
41. Aloia M.S., Stanchina M., Arnedt J.T., et al. Treatment adherence and outcomes in flexible vs standard continuous positive airway pressure therapy. Chest 127 6 (2005) 2085-2093
42. Gay P.C., Herold D.L., and Olson E.J. A randomized, double-blind clinical trial comparing continuous positive airway pressure with a novel bilevel pressure system for treatment of obstructive sleep apnea syndrome. Sleep 26 7 (2003) 864-869
43. Nilius G., Happel A., Domanski U., et al. Pressure-relief continuous positive airway pressure vs constant continuous positive airway pressure: a comparison of efficacy and compliance. Chest 130 4 (2006) 1018-1024
44. Pepin J.L., Leger P., Veale D., et al. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest 107 2 (1995) 375-381
45. Jarjour N.N., and Wilson P. Pneumocephalus associated with nasal continuous positive airway pressure in a patient with sleep apnea syndrome. Chest 96 6 (1989) 1425-1426
46. McEachern R.C., and Patel R.G. Pneumopericardium associated with face-mask continuous positive airway pressure. Chest 112 5 (1997) 1441-1443
47. Bamford C.R., and Quan S.F. Bacterial meningitis-a possible complication of nasal continuous positive airway pressure therapy in a patient with obstructive sleep apnea syndrome and a mucocele. Sleep 16 1 (1993) 31-32
48. Farre R., Montserrat J.M., Ballester E., et al. Potential rebreathing after continuous positive airway pressure failure during sleep. Chest 121 1 (2002) 196-200
49. Weaver T.E., Kribbs N.B., Pack A.I., et al. Night-to-night variability in CPAP use over the first three months of treatment. Sleep 20 4 (1997) 278-283
50. Kribbs N.B., Pack A.I., Kline L.R., et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 147 4 (1993) 887-895
51. Kushida C.A., Littner M.R., Hirshkowitz M., et al. American Academy of Sleep Medicine. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 29 3 (2006) 375-380
52. Meurice J.C., Dore P., Paquereau J., et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 105 2 (1994) 429-433
53. Engleman H.M., Asgari-Jirhandeh N., McLeod A.L., et al. Self-reported use of CPAP and benefits of CPAP therapy. A patient survey. Chest 109 6 (1996) 1470-1476
54. Weaver T.E., Maislin G., Dinges D.F., et al. Self-efficacy in sleep apnea: instrument development and patient perceptions of obstructive sleep apnea risk, treatment benefit, and volition to use continuous positive airway pressure. Sleep 26 6 (2003) 727-732
55. McArdle N., Devereux G., Heidarnejad H., et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159 4 Pt 1 (1999) 1108-1114
56. Scharf S.M., Seiden L., DeMore J., et al. Racial differences in clinical presentation of patients with sleep-disordered breathing. Sleep Breath 8 4 (2004) 173-183
57. Engleman H.M., and Wild M.R. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev 7 1 (2003) 81-99
58. Engleman H.E., Martin S.E., and Douglas N.J. Compliance with CPAP therapy in patients with the sleep apnea/hypopnea syndrome. Thorax 49 3 (1994) 263-266
59. Prosise G.L., and Berry R.B. Oral-nasal continuous positive airway pressure as a treatment for obstructive sleep apnea. Chest 106 1 (1994) 180-186
60. Mortimore I.L., Whittle A.T., and Douglas N.J. Comparison of nose and face mask CPAP therapy for sleep apnoea. Thorax 53 4 (1998) 290-292
61. Edinger J.D., and Radtke R.A. Use of in vivo desensitization to treat a patient's claustrophobic response to nasal CPAP. Sleep 16 7 (1993) 678-680
62. Khanna R., and Kline L.R. A prospective 8 week trial of nasal interfaces vs. a novel oral interface (Oracle) for treatment of obstructive sleep apnea hypopnea syndrome. Sleep Med 4 4 (2003) 333-338
63. Anderson F.E., Kingshott R.N., Taylor D.R., et al. A randomized crossover efficacy trial of oral CPAP (Oracle) compared with nasal CPAP in the management of obstructive sleep apnea. Sleep 26 6 (2003) 721-726
64. Beecroft J., Zanon S., Lukic D., et al. Oral continuous positive airway pressure for sleep apnea: effectiveness, patient preference, and adherence. Chest 124 6 (2003) 2200-2208
65. Massie C.A., and Hart R.W. Clinical outcomes related to interface type in patients with obstructive sleep apnea/hypopnea syndrome who are using continuous positive airway pressure. Chest 123 4 (2003) 1112-1118
66. Baltzan M.A., Kassissia I., Elkholi O., et al. Prevalence of persistent sleep apnea in patients treated with continuous positive airway pressure. Sleep 29 4 (2006) 557-563
67. Richards G.N., Cistulli P.A., Ungar R.G., et al. Mouth leaks and increased nasal resistance. Am J Respir Crit Care Med 154 1 (1996) 182-186
68. Togias A.G., Naclerio R.M., Peters S.P., et al. Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold, dry air. Am Rev Respir Dis 133 6 (1986) 1133-1137
69. Massie C.A., Hart R.W., Peralez K., et al. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 116 2 (1999) 403-408
70. Rakotonanahary D., Pelletier-Fleury N., Gagnadoux F., et al. Predictive factors for the need for additional humidification during nasal continuous positive airway pressure therapy. Chest 119 2 (2001) 460-465
71. Mador M.J., Krauza M., Pervez A., et al. Effect of heated humidification on compliance and quality of life in patients with sleep apnea using nasal continuous positive airway pressure. Chest 128 4 (2005) 2151-2158
72. Powell N.B., Zonato A.I., Weaver E.M., et al. Radiofrequency treatment of turbinate hypertrophy in subjects using continuous positive airway pressure: a randomized, double-blind, placebo-controlled clinical pilot trial. Laryngoscope 111 10 (2001) 1783-1790
73. Sin D.D., Mayers I., and Man G.C. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apneas: a population based study. Chest 121 2 (2002) 430-435
74. Hoy C.J., Vennelle M., Kingshott R.N., et al. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome?. Am J Respir Crit Care Med 159 4 Pt 1 (1999) 1096-1100
75. Chervin R.D., Theut S., Bassetti C., et al. Compliance with nasal CPAP can be improved by simple interventions. Sleep 20 4 (1997) 284-289
76. Jean Wiese H., Boethel C., Phillips B., et al. CPAP compliance: video education may help!. Sleep Med 6 2 (2005) 171-174
77. Stepnowsky Jr. C.J., Bardwell W.A., Moore P.J., et al. Psychologic correlates of compliance with continuous positive airway pressure. Sleep 25 7 (2002) 758-762
78. Aloia M.S., Di Dio L., Ilniczky N., et al. Improving compliance with nasal CPAP and vigilance in older adults with OAHS. Sleep Breath 5 1 (2001) 13-21
79. Farre R., Hernandez L., Montserrat J., et al. Sham continuous CPAP for placebo-controlled studies in sleep apnea. Lancet 353 9159 (1999) 1154
80. Dimsdale J.D., Loredo J.S., and Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 35 1 Pt 1 (2000) 144-147
81. Faccenda J., Mackay T.M., Boon N.A., et al. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 163 2 (2001) 344-348
82. Hla M., Skatrud J.B., Finn L., et al. The effect of correction of sleep-disordered breathing on BP in untreated hypertension. Chest 122 4 (2002) 1125-1132
83. Becker H.F., Jerrentrup A., Ploch T., et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107 1 (2003) 68-73
84. Waradekar N.V., Sinoway L.I., Zwillich C.W., et al. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153 4 Pt 1 (1996) 1333-1338
85. Campos-Rodriguez F., Grilo-Reina A., Perez-Ronchel J., et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 129 6 (2006) 1459-1467
86. Kaneko Y., Floras J.S., Usui K., et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348 13 (2003) 1233-1241
87. Malone S., Liu P.P., Holloway R., et al. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 338 8781 (1991) 1480-1484
88. Mansfield D.R., Gollogly N.C., Kaye D.M., et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169 3 (2004) 361-366
89. Buckle P., Millar T., and Kryger M. The effect of short-term nasal CPAP on Cheyne-Stokes respiration in congestive heart failure. Chest 102 1 (1992) 31-35
90. Naughton M.T., Liu P.P., Bernard D.C., et al. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 151 1 (1995) 92-97
91. Bradley T.D., Logan A.G., Kimoff R.J., et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 353 19 (2005) 2025-2033
92. Bassetti C.L., Milanova M., and Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 37 4 (2006) 967-972
93. Campos-Rodriguez F., Pena-Grinan N., Reyes-Nunez N., et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 128 2 (2005) 624-633
94. Engleman H.M., Martin S.E., Deary I.J., et al. Effect of continuous positive airway pressure treatment on daytime function in sleep apnea/hypopnea syndrome. Lancet 343 8897 (1994) 572-575
95. Engleman H.M., Martin S.E., Deary I.J., et al. Effect of CPAP therapy on daytime function in patients with mild sleep apnea/hypopnea syndrome. Thorax 52 2 (1997) 114-119
96. Jenkinson C., Davies R.J., Mullins R., et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnea: a randomized prospective parallel trial. Lancet 353 9170 (1999) 2100-2105
97. McFadyen T.A., Espie C.A., McArdle N., et al. Controlled, prospective trial of psychosocial function before and after continuous positive airway pressure therapy. Eur Respir J 18 6 (2001) 996-1002
98. Sin D.D., Mayers I., Man G.C.W., et al. Can continuous positive airway pressure therapy improve the general health status of patients with obstructive sleep apnea? A clinical effectiveness study. Chest 122 5 (2002) 1679-1685
99. George C.F. Reduction in motor vehicle collisions following treatment of sleep apnea with nasal CPAP. Thorax 56 7 (2001) 508-512
100. McArdle N., Kingshott R., Engleman H.M., et al. Partners of patients with sleep apnea/hypopnea syndrome: effect of CPAP treatment on sleep quality and quality of life. Thorax 56 7 (2001) 513-518
101. Patel S.R., White D.P., Malhotra A., et al. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a metaanalysis. Arch Intern Med 163 5 (2003) 565-571
102. Sforza E., and Krieger J. Daytime sleepiness after long-term continuous positive airway pressure (CPAP) treatment in obstructive sleep apnea syndrome. J Neurol Sci 110 1-2 (1992) 21-26
103. Bedard M.-A., Montplaisir J., Malo J., et al. Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). J Clin Exp Neuropsychol 15 2 (1993) 330-341
104. Pack A., Black J., Schwartz J., et al. Modafinil as an adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med 164 9 (2001) 1675-1681
105. Kingshott R.N., Venelle M., Coleman E.L., et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 163 4 (2001) 918-923
106. Black J., and Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea-hypopnea syndrome. Sleep 28 4 (2005) 464-471
107. Tarasiuk A., Greenberg-Dotan S., Brin Y.S., et al. Determinants affecting health-care utilization in OSAS patients. Chest 128 3 (2005) 1310-1314
108. Ayas N.T., FitzGerald J.M., Fleetham J.A., et al. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med 166 9 (2006) 977-984